Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for February 2, 2005 Subscribe to this News Feed      
 

Could Vioxx Have Caused Death, Stroke or a Heart Attack?

The arthritis drug Vioxx was pulled from the market in September 2004, after studies showed Vioxx doubled patients' risk of heart attack and stroke. Evidence is mounting, however, that the company knew of these side effects as early as 2000, but sold the drug anyway.

(PRWEB) February 2, 2005 -- Vioxx, a COX-2 inhibitor, was a blockbuster drug for arthritis related joint pain. Bringing in $2.5 billion in sales for the pharmaceutical giant Merck in 2003, Vioxx was a hit with sufferers of arthritis worldwide. But, patients were unaware that the arthritis drug that they were prescribed possibly increased their chances of heart attack and stroke by 200%. How were they to know? Everywhere patients looked, commercials and doctors suggested the drug, touting its benefits.

Its not clear how many people may have suffered a stroke, heart attack, or even death due to Vioxx. According to FDA employee and whistleblower David Graham, between 88,000 and 139,000 people in the United States have suffered Vioxx heart attacks and Vioxx related strokes. As many as 40 percent of those who suffered, died as a result. (Corporate Crime Reporter, 3 January 2005)

Could this have been avoided? Although the drug was pulled from the shelves, after a conclusive study in 2004 found that people using Vioxx for 18 months or more greatly increased their chances for heart attack or stroke, a study performed by Merck back in 2000 showed that patients who took Vioxx had an increased risk of developing heart problems. (NapaNews.com, 9 January 2005). Merck apparently decided not to publish those findings, and instead brought the drug to market.

The FDA has ordered an investigation of Vioxx heart attacks, strokes, and deaths. As evidence of negligence mounts against Merck, it is recommended that patients and their families investigate what medications were taken in the past and compare that to any new health conditions they now have.

Vioxx lawsuits are being filed throughout the U.S. against Merck for the companys role in vigorously advertising the drug while possibly keeping the drug's side effects secret from patients and doctors.

LegalServicesInfo.com is a Vioxx lawsuit site that links people who have Vioxx related health concerns with Vioxx attorneys and Vioxx law firms who practice in product liabilty cases. Patients and family members of those suffering from Vioxx side effects can fill out their information on a brief form and have their case evaluated for free by a team of attorneys specializing in product liability and class action cases.

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
John Dalton
REGENCY MARKETING
561-499-3329
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright